Product Code: GVR-4-68038-186-3
Advanced Wound Care Market Growth & Trends:
The global advanced wound care market size is anticipated to reach USD 14.87 billion by 2030, registering a CAGR of 4.75% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growth in the number of the aging population as well as an increasing figure of diabetic patients are some major factors driving this market's growth.
For instance, as per a United Health Foundation report (published in May 2023), more than 55.8 million adults aged 65 and older lived in the U.S., accounting for about 16.8% of the nation's population in 2021, increasing the number of senior populations is anticipated to propel the market during the forecast period.
There has been growth in the number of surgical procedures, and traumatic incidents globally. For instance, as per a study by Research Gate, in 2022, around 6.6% of mortality occurs due to trauma every year. Similarly, there has been an increase in the number of surgical site infections. Advanced wound care products help to contain and reduce these surgical site infections, thereby, an increase in the number of surgical site infections is expected to drive the market during the forecast period.
The introduction of the COVID-19 vaccine, and the lifting of lockdown impositions, are expected to have a positive impact on the market over the forecast period. Many elective surgeries, which were postponed, are expected to take place. In addition to this, many leading manufacturers are introducing new products which may help them to capitalize on the increasing demand for advanced wound care products during the forecast period.
Advanced Wound Care Market Report Highlights:
- Based on product, the moist wound care segment led the market with the largest revenue share of 71.13% in 2023. This dominance can be attributed to an increase in a number of wound cases and increase in number of surgeries globally.
- In terms of application, the chronic wounds segment is dominate the market with the largest revenue share in 2023. Increasing number of diabetic foot ulcers, venous pressure ulcers, and other chronic wounds is expected to drive the segment growth.
- Based on end-use, the hospital segment held the market with the largest revenue share of 45.19% in 2023. The growth of this segment can be attributed to the upsurge in surgical procedures and increase in the number of hospital admissions.
- North America dominated the market with the revenue share of 45.43% in 2023. This dominance can be attributed to well-developed healthcare infrastructure and increase in the number of surgical procedures.
- Asia Pacific is anticipated to witness significant CAGR during the forecast period. This can be attributed to the presence of major key players, the increasing prevalence of chronic disorders, and rising healthcare expenditure.
Table of Contents
Chapter 1. Advanced Wound Care Market: Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.5. Details of primary research
- 1.5.1. Data for primary interviews in North America
- 1.5.2. Data for primary interviews in Europe
- 1.5.3. Data for primary interviews in Asia Pacific
- 1.5.4. Data for primary interviews in Latin America
- 1.5.5. Data for Primary interviews in MEA
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.1.1. Approach 1: Commodity flow approach
- 1.7.2. Volume price analysis (Model 2)
- 1.7.2.1. Approach 2: Volume price analysis
- 1.8. Research Scope and Assumptions
- 1.8.1. List of Secondary Sources
- 1.8.2. List of Primary Sources
- 1.8.3. Objectives
Chapter 2. Advanced Wound Care Market: Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Advanced Wound Care Market: Wound Care Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Drivers Analysis
- 3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
- 3.2.1.2. Introduction of innovative and advanced wound products
- 3.2.1.3. Rising geriatric population
- 3.2.1.4. Increasing number of road accidents, trauma cases, and burns
- 3.2.1.5. Increasing number of surgeries
- 3.2.2. Market Restraints Analysis
- 3.2.2.1. Delayed Diagnosis and lower treatment rates in emerging nations
- 3.3. Advanced Wound Care Market Analysis Tools
- 3.3.1. Porter's Analysis
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.2.5. Legal landscape
Chapter 4. Advanced Wound Care Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Advanced Wound Care Market: Product Movement Analysis, 2023 & 2030 (USD Million)
- 4.3. Moist Wound Care
- 4.3.1. Moist wound care market revenue estimates and forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Foam dressings
- 4.3.2.1. Foam dressings market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 4.3.3. Hydrocolloid dressings
- 4.3.3.1. Hydrocolloid dressings market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 4.3.4. Film dressings
- 4.3.4.1. Film dressings market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 4.3.5. Alginate dressings
- 4.3.5.1. Alginate dressings market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 4.3.6. Hydrogel dressings
- 4.3.6.1. Hydrogel dressings market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 4.3.7. Collagen dressings
- 4.3.7.1. Collagen dressings market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 4.3.8. Other advanced dressings
- 4.3.8.1. Other advanced dressings market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 4.4. Antimicrobial
- 4.4.1. Antimicrobial market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 4.4.2. Silver
- 4.4.2.1. Silver market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 4.4.3. Non-silver
- 4.4.3.1. Non-silver market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 4.5. Active Wound Care
- 4.5.1. Active wound care market revenue estimates and forecasts, 2018 - 2030 (USD Million)
- 4.5.2. Biomaterials
- 4.5.2.1. Biomaterials market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 4.5.3. Skin-substitute
- 4.5.3.1. Skin-substitute market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 4.5.4. Growth factors
- 4.5.4.1. Growth factors market revenue estimates and forecasts, 2018 - 2030 (USD million)
Chapter 5. Advanced Wound Care Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Advanced Wound Care Market: Application Movement Analysis, 2023 & 2030 (USD Million)
- 5.3. Chronic Wounds
- 5.3.1. Chronic wounds market revenue estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3.2. Diabetic foot ulcer
- 5.3.2.1. Diabetic foot ulcer market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 5.3.3. Pressure ulcer
- 5.3.3.1. Pressure ulcer market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 5.3.4. Venous leg ulcer
- 5.3.4.1. Venous leg ulcer market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 5.3.5. Others
- 5.3.5.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 5.4. Acute Wounds
- 5.4.1. Acute wounds market revenue estimates and forecasts, 2018 - 2030 (USD Million)
- 5.4.2. Surgical & traumatic wounds
- 5.4.2.1. Surgical & traumatic wounds market revenue estimates and forecasts, 2018 - 2030 (USD million)
- 5.4.3. Burns
- 5.4.3.1. Burns market revenue estimates and forecasts, 2018 - 2030 (USD million)
Chapter 6. Advanced Wound Care Market: End use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Advanced Wound Care Market: End use Movement Analysis, 2023 & 2030 (USD Million)
- 6.3. Hospitals
- 6.3.1. Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
- 6.4. Specialty Clinics
- 6.4.1. Specialty clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
- 6.5. Home healthcare
- 6.5.1. Home healthcare market revenue estimates and forecasts, 2018 - 2030 (USD Million)
- 6.6. Others
- 6.6.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Advanced Wound Care Market: Regional Estimates & Trend Analysis
- 7.1. Advanced Wound Care Market Share, By Region, 2023 & 2030, USD Million
- 7.2. North America
- 7.2.1. North America advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. Key country dynamics
- 7.2.2.2. Competitive scenario
- 7.2.2.3. Regulatory framework
- 7.2.2.4. Reimbursement scenario
- 7.2.2.5. U.S. advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Key country dynamics
- 7.2.3.2. Competitive scenario
- 7.2.3.3. Regulatory framework
- 7.2.3.4. Reimbursement scenario
- 7.2.3.5. Canada advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3. Europe
- 7.3.1. Europe advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.2. U.K.
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Competitive scenario
- 7.3.2.3. Regulatory framework
- 7.3.2.4. Reimbursement scenario
- 7.3.2.5. U.K. advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Competitive scenario
- 7.3.3.3. Regulatory framework
- 7.3.3.4. Reimbursement scenario
- 7.3.3.5. Germany advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.4. France
- 7.3.4.1. Key country dynamics
- 7.3.4.2. Competitive scenario
- 7.3.4.3. Regulatory framework
- 7.3.4.4. Reimbursement scenario
- 7.3.4.5. France advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.5. Italy
- 7.3.5.1. Key country dynamics
- 7.3.5.2. Competitive scenario
- 7.3.5.3. Regulatory framework
- 7.3.5.4. Reimbursement scenario
- 7.3.5.5. Italy advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Spain
- 7.3.6.1. Key country dynamics
- 7.3.6.2. Competitive scenario
- 7.3.6.3. Regulatory framework
- 7.3.6.4. Reimbursement scenario
- 7.3.6.5. Spain advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.7. Sweden
- 7.3.7.1. Key country dynamics
- 7.3.7.2. Competitive scenario
- 7.3.7.3. Regulatory framework
- 7.3.7.4. Reimbursement scenario
- 7.3.7.5. Sweden advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Denmark
- 7.3.8.1. Key country dynamics
- 7.3.8.2. Competitive scenario
- 7.3.8.3. Regulatory framework
- 7.3.8.4. Reimbursement scenario
- 7.3.8.5. Denmark advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.3.9. Norway
- 7.3.9.1. Key country dynamics
- 7.3.9.2. Competitive scenario
- 7.3.9.3. Regulatory framework
- 7.3.9.4. Reimbursement scenario
- 7.3.9.5. Norway advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.2. China
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Competitive scenario
- 7.4.2.3. Regulatory framework
- 7.4.2.4. Reimbursement scenario
- 7.4.2.5. China advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Japan
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Competitive scenario
- 7.4.3.3. Regulatory framework
- 7.4.3.4. Reimbursement scenario
- 7.4.3.5. Japan advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Competitive scenario
- 7.4.4.3. Regulatory framework
- 7.4.4.4. Reimbursement scenario
- 7.4.4.5. India advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.5. South Korea
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Competitive scenario
- 7.4.5.3. Regulatory framework
- 7.4.5.4. Reimbursement scenario
- 7.4.5.5. South Korea advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Australia
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Competitive scenario
- 7.4.6.3. Regulatory framework
- 7.4.6.4. Reimbursement scenario
- 7.4.6.5. Australia advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Competitive scenario
- 7.4.7.3. Regulatory framework
- 7.4.7.4. Reimbursement scenario
- 7.4.7.5. Thailand advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Competitive scenario
- 7.5.2.3. Regulatory framework
- 7.5.2.4. Reimbursement scenario
- 7.5.2.5. Brazil advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Mexico
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Competitive scenario
- 7.5.3.3. Regulatory framework
- 7.5.3.4. Reimbursement scenario
- 7.5.3.5. Mexico advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.4. Argentina
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Competitive scenario
- 7.5.4.3. Regulatory framework
- 7.5.4.4. Reimbursement scenario
- 7.5.4.5. Argentina advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6. Middle East and Africa
- 7.6.1. Middle East and Africa advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Saudi Arabia
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Competitive scenario
- 7.6.2.3. Regulatory framework
- 7.6.2.4. Reimbursement scenario
- 7.6.2.5. Saudi Arabia advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.3. UAE
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Competitive scenario
- 7.6.3.3. Regulatory framework
- 7.6.3.4. Reimbursement scenario
- 7.6.3.5. UAE advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.4. South Africa
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Competitive scenario
- 7.6.4.3. Regulatory framework
- 7.6.4.4. Reimbursement scenario
- 7.6.4.5. South Africa advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Competitive scenario
- 7.6.5.3. Regulatory framework
- 7.6.5.4. Reimbursement scenario
- 7.6.5.5. Kuwait advanced wound care market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis by Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Market Share Analysis
- 8.4. Company Heat Map Analysis
- 8.5. Strategy Mapping
- 8.5.1. Expansion
- 8.5.2. Mergers & Acquisition
- 8.5.3. Partnerships & Collaborations
- 8.5.4. New Product Launches
- 8.5.5. Research And Development
- 8.5.6. Company Profiles
- 8.5.7. ConvaTec Group PLC
- 8.5.7.1. Company overview
- 8.5.7.2. Financial performance
- 8.5.7.3. Product Benchmarking
- 8.5.7.4. Strategic initiatives
- 8.5.8. Smith & Nephew PLC
- 8.5.8.1. Company overview
- 8.5.8.2. Financial performance
- 8.5.8.3. Product Benchmarking
- 8.5.8.4. Strategic initiatives
- 8.5.9. Molnlycke Health Care AB
- 8.5.9.1. Company overview
- 8.5.9.2. Financial performance
- 8.5.9.3. Product Benchmarking
- 8.5.9.4. Strategic initiatives
- 8.5.10. B. Braun Melsungen AG
- 8.5.10.1. Company overview
- 8.5.10.2. Financial performance
- 8.5.10.3. Product Benchmarking
- 8.5.10.4. Strategic initiatives
- 8.5.11. 3M
- 8.5.11.1. Company overview
- 8.5.11.2. Financial performance
- 8.5.11.3. Product Benchmarking
- 8.5.11.4. Strategic initiatives
- 8.5.12. URGO
- 8.5.12.1. Company overview
- 8.5.12.2. Financial performance
- 8.5.12.3. Product Benchmarking
- 8.5.12.4. Strategic initiatives
- 8.5.13. Coloplast Corp.
- 8.5.13.1. Company overview
- 8.5.13.2. Financial performance
- 8.5.13.3. Product Benchmarking
- 8.5.13.4. Strategic initiatives
- 8.5.14. Integra LifeSciences
- 8.5.14.1. Company overview
- 8.5.14.2. Financial performance
- 8.5.14.3. Product Benchmarking
- 8.5.14.4. Strategic initiatives
- 8.5.15. Medline Industries, Inc.
- 8.5.15.1. Company overview
- 8.5.15.2. Financial performance
- 8.5.15.3. Product Benchmarking
- 8.5.15.4. Strategic initiatives